Home LiteratureArticle Details
PMID: 9557739 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

PITALRE, the catalytic subunit of TAK, is required for human immunodeficiency virus Tat transactivation in vivo.

Journal of virology ·Vol. 72 ·No. 5 ·1998-05-00 ·Pages 4448-53

Gold MO, Yang X, Herrmann CH, Rice AP

Abstract

The human cdc2-related kinase PITALRE is the catalytic component of TAK, the Tat-associated kinase. Previously, we have proposed that TAK is a cellular factor that mediates Tat transactivation function. Here we demonstrate that transient overexpression of PITALRE specifically squelches Tat-1 activation of both a transfected and an integrated human immunodeficiency virus type 1 (HIV-1) long terminal repeat (LTR), suggesting that PITALRE mediates Tat function as a multiprotein complex. A catalytic mutant of PITALRE, D167N, was found to be more efficient than wild-type PITALRE in squelching Tat transactivation. Neither wild-type PITALRE nor D167N was able to squelch transactivation of the human T-cell leukemia type 1 LTR by the Tax protein. Additionally, we show that artificial targeting of PITALRE to a nascent RNA element, in the absence of Tat, activated HIV-1 LTR expression. These results indicate that a PITALRE-containing complex mediates transactivation by Tat and suggest that Tat proteins function by localizing such a PITALRE-containing complex to the site of the transcribing provirus.

MeSH Terms
Artificial Gene Fusion Catalysis Cyclin-Dependent Kinase 9 Gene Expression Gene Products, tat/genetics Genes, rev HIV Long Terminal Repeat HIV-1/genetics HeLa Cells Humans Mutagenesis Positive Transcriptional Elongation Factor B Protein Kinases/genetics,metabolism Protein Serine-Threonine Kinases/genetics,metabolism Transcriptional Activation Virus Integration tat Gene Products, Human Immunodeficiency Virus
Chemicals
Gene Products, tat tat Gene Products, Human Immunodeficiency Virus Protein Kinases Positive Transcriptional Elongation Factor B Protein Serine-Threonine Kinases CDK9 protein, human Cyclin-Dependent Kinase 9
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Gold M O
Division of Molecular Virology, Baylor College of Medicine, Houston, Texas 77030, USA.
Yang X
Herrmann C H
Rice A P
References (47)
47 references, click to expand
  1. Phosphorylation of RNA polymerase II C-terminal domain and transcriptional elongation.
    Nature. 1994 Jul 7;370(6484):75-7 PMID: 8015613
  2. PITALRE, a nuclear CDC2-related protein kinase that phosphorylates the retinoblastoma protein in vitro.
    Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3834-8 PMID: 8170997
  3. Exon2 of HIV-2 Tat contributes to transactivation of the HIV-2 LTR by increasing binding affinity to HIV-2 TAR RNA.
    Nucleic Acids Res. 1994 Oct 25;22(21):4405-13 PMID: 7971271
  4. Control of RNA initiation and elongation at the HIV-1 promoter.
    Annu Rev Biochem. 1994;63:717-43 PMID: 7979253
  5. Novel mechanism and factor for regulation by HIV-1 Tat.
    EMBO J. 1995 Jan 16;14(2):321-8 PMID: 7835343
  6. Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: candidate for a Tat cofactor.
    J Virol. 1995 Mar;69(3):1612-20 PMID: 7853496
  7. Functional similarities between HIV-1 Tat and DNA sequence-specific transcriptional activators.
    Virology. 1995 Feb 1;206(2):1150-4 PMID: 7856090
  8. A kinase-cyclin pair in the RNA polymerase II holoenzyme.
    Nature. 1995 Mar 9;374(6518):193-6 PMID: 7877695
  9. Transcriptional trans activation by human immunodeficiency virus type 1 Tat requires specific coactivators that are not basal factors.
    J Virol. 1995 May;69(5):3098-107 PMID: 7707538
  10. Cyclin-dependent protein kinase and cyclin homologs SSN3 and SSN8 contribute to transcriptional control in yeast.
    Proc Natl Acad Sci U S A. 1995 Apr 25;92(9):4006-10 PMID: 7732022
  11. Identification of genes required for alpha 2 repression in Saccharomyces cerevisiae.
    Genetics. 1995 May;140(1):79-90 PMID: 7635311
  12. The transcriptional elongation inhibitor 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole inhibits transcription factor IIH-associated protein kinase.
    J Biol Chem. 1995 Oct 13;270(41):23922-5 PMID: 7592583
  13. A human RNA polymerase II complex associated with SRB and DNA-repair proteins.
    Nature. 1996 May 2;381(6577):86-9 PMID: 8609996
  14. The human immunodeficiency virus Tat proteins specifically associate with TAK in vivo and require the carboxyl-terminal domain of RNA polymerase II for function.
    J Virol. 1996 Jul;70(7):4576-84 PMID: 8676484
  15. DRB-induced premature termination of late adenovirus transcription.
    Nature. 1978 Apr 13;272(5654):590-3 PMID: 643052
  16. Early termination of heterogeneous nuclear RNA transcripts in mammalian cells: accentuation by 5,6-dichloro 1-beta-D-ribofuranosylbenzimidazole.
    Proc Natl Acad Sci U S A. 1979 Nov;76(11):5750-4 PMID: 293679
  17. Location of the trans-activating region on the genome of human T-cell lymphotropic virus type III.
    Science. 1985 Jul 5;229(4708):74-7 PMID: 2990041
  18. Casein kinase type II is involved in the inhibition by 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole of specific RNA polymerase II transcription.
    J Biol Chem. 1986 Mar 5;261(7):3414-9 PMID: 3456346
  19. The trans-activator gene of the human T cell lymphotropic virus type III is required for replication.
    Cell. 1986 Mar 28;44(6):941-7 PMID: 2420471
  20. The trans-activator gene of HTLV-III is essential for virus replication.
    Nature. 1986 Mar 27-Apr 2;320(6060):367-71 PMID: 3007995
  21. Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product.
    Nature. 1987 Dec 3-9;330(6147):489-93 PMID: 2825027
  22. Human immunodeficiency virus type 2 long terminal repeat: analysis of regulatory elements.
    Proc Natl Acad Sci U S A. 1988 Dec;85(24):9753-7 PMID: 2849115
  23. HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation.
    Cell. 1989 Oct 20;59(2):283-92 PMID: 2553266
  24. The transition of RNA polymerase II from initiation to elongation is associated with phosphorylation of the carboxyl-terminal domain of subunit IIa.
    J Biol Chem. 1989 Nov 25;264(33):19621-9 PMID: 2584185
  25. Reversible phosphorylation of the C-terminal domain of RNA polymerase II.
    J Biol Chem. 1996 Aug 9;271(32):19009-12 PMID: 8759772
  26. Regulation of HIV gene expression.
    AIDS. 1995;9 Suppl A:S19-32 PMID: 8819566
  27. Tat-SF1: cofactor for stimulation of transcriptional elongation by HIV-1 Tat.
    Science. 1996 Oct 25;274(5287):605-10 PMID: 8849451
  28. The CDC2-related kinase PITALRE is the catalytic subunit of active multimeric protein complexes.
    Biochem J. 1996 Oct 1;319 ( Pt 1):293-8 PMID: 8870681
  29. Trans-activation by human immunodeficiency virus Tat protein requires the C-terminal domain of RNA polymerase II.
    Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11575-9 PMID: 8876177
  30. Requirements for RNA polymerase II carboxyl-terminal domain for activated transcription of human retroviruses human T-cell lymphotropic virus I and HIV-1.
    J Biol Chem. 1996 Nov 1;271(44):27888-94 PMID: 8910388
  31. Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxy-terminal domain.
    Nature. 1996 Nov 28;384(6607):375-8 PMID: 8934526
  32. Purification of a Tat-associated kinase reveals a TFIIH complex that modulates HIV-1 transcription.
    EMBO J. 1997 May 15;16(10):2836-50 PMID: 9184228
  33. CDC2-related kinase PITALRE phosphorylates pRb exclusively on serine and is widely expressed in human tissues.
    J Cell Physiol. 1997 Aug;172(2):265-73 PMID: 9258347
  34. Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro.
    Genes Dev. 1997 Oct 15;11(20):2622-32 PMID: 9334325
  35. P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro.
    Genes Dev. 1997 Oct 15;11(20):2633-44 PMID: 9334326
  36. TAK, an HIV Tat-associated kinase, is a member of the cyclin-dependent family of protein kinases and is induced by activation of peripheral blood lymphocytes and differentiation of promonocytic cell lines.
    Proc Natl Acad Sci U S A. 1997 Nov 11;94(23):12331-6 PMID: 9356449
  37. Trans-activation by HIV-1 Tat via a heterologous RNA binding protein.
    Cell. 1990 Aug 24;62(4):769-76 PMID: 2117500
  38. HIV-1 Tat protein trans-activates transcription in vitro.
    Cell. 1990 Nov 16;63(4):791-802 PMID: 2225077
  39. Sp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat protein.
    Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8510-4 PMID: 1924310
  40. The HIV-1 Tat protein activates transcription from an upstream DNA-binding site: implications for Tat function.
    Genes Dev. 1991 Dec;5(12B):2496-507 PMID: 1752440
  41. HIV-1 Tat protein promotes formation of more-processive elongation complexes.
    EMBO J. 1991 Dec;10(13):4189-96 PMID: 1756726
  42. Inhibition of human immunodeficiency virus type 1 Tat activity by coexpression of heterologous trans activators.
    J Virol. 1992 Apr;66(4):2000-7 PMID: 1312617
  43. Control of formation of two distinct classes of RNA polymerase II elongation complexes.
    Mol Cell Biol. 1992 May;12(5):2078-90 PMID: 1569941
  44. The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence.
    Genes Dev. 1992 Nov;6(11):2077-87 PMID: 1427073
  45. Genetic analysis of the cofactor requirement for human immunodeficiency virus type 1 Tat function.
    J Virol. 1993 Jul;67(7):3703-11 PMID: 8389901
  46. Specific interaction of the human immunodeficiency virus Tat proteins with a cellular protein kinase.
    Virology. 1993 Dec;197(2):601-8 PMID: 8249283
  47. A sensitive reporter cell line for HIV-1 tat activity, HIV-1 inhibitors, and T cell activation effects.
    AIDS Res Hum Retroviruses. 1994 Mar;10(3):295-301 PMID: 8018390
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1998-05-00
Pages
4448-53
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC109679
Subset
IM
Grants
NIAID NIH HHS · T32 AI07483 · United States
NIAID NIH HHS · T32 AI007483 · United States
NIAID NIH HHS · R01 AI035381 · United States
NIAID NIH HHS · AI35381 · United States
NIAID NIH HHS · R56 AI035381 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]